Lyme borreliosis: New approach for developing targeted therapy

Lyme borreliosis is the most common tick-borne infectious disease in Europe. Up to 70,000 new cases are estimated each year in Austria alone. The bacterial infection can cause lasting health problems for patients. A research team has made significant progress in understanding the mechanism of infection and identified a potential way forward for the development of targeted therapies that do not rely on antibiotics.